(Q34983265)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12405866%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

review article

1 reference

title

Interactions between antiretroviral drugs and drugs used for the therapy of the metabolic complications encountered during HIV infection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12405866%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

main subject

anti-retroviral agent

0 references

author

Carl Fichtenbaum

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12405866%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

author name string

John G Gerber

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12405866%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

publication date

1 January 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12405866%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacokinetics

14 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12405866%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

volume

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12405866%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

issue

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12405866%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

page(s)

1195-1211

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12405866%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/00003088-200241140-00004

14 December 2019

exact match

0 references

1 reference

12 December 2020

Effects of grapefruit juice on the stereoselective disposition of nicardipine in humans: evidence for dominant presystemic elimination at the gut site

1 reference

12 December 2020

Effects of fluconazole and fluvoxamine on the pharmacokinetics and pharmacodynamics of glimepiride

1 reference

12 December 2020

Effects of grapefruit juice ingestion--pharmacokinetics and haemodynamics of intravenously and orally administered felodipine in healthy men.

1 reference

12 December 2020

Identification of the rabbit and human cytochromes P-450IIIA as the major enzymes involved in the N-demethylation of diltiazem

1 reference

12 December 2020

Clinical pharmacokinetics of non-nucleoside reverse transcriptase inhibitors

1 reference

12 December 2020

Microsomal metabolism of delavirdine: evidence for mechanism-based inactivation of human cytochrome P450 3A

1 reference

12 December 2020

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

1 reference

12 December 2020

In-vitro and in-vivo pharmacokinetic interactions of amprenavir, an HIV protease inhibitor, with other current HIV protease inhibitors in rats

1 reference

12 December 2020

Phenotypic and genotypic investigations of a healthy volunteer deficient in the conversion of losartan to its active metabolite E-3174

1 reference

12 December 2020

Biotransformation of lovastatin. I. Structure elucidation of in vitro and in vivo metabolites in the rat and mouse

1 reference

12 December 2020

Hepatic dysfunction associated with troglitazone

1 reference

12 December 2020

Clinical pharmacokinetics of angiotensin II (AT1) receptor blockers in hypertension

1 reference

12 December 2020

The effects of a cardioselective (metoprolol) and a nonselective (propranolol) beta-adrenergic blocker on the response to dynamic exercise in normal men

1 reference

12 December 2020

Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors.

1 reference

12 December 2020

Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance.

1 reference

12 December 2020

Pharmacokinetics of alendronate

1 reference

12 December 2020

Drug treatment of lipid disorders

1 reference

12 December 2020

Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences

1 reference

12 December 2020

Characterization of the cytochrome P450 enzymes involved in the in vitro metabolism of rosiglitazone

1 reference

12 December 2020

Calcium-antagonist drugs

1 reference

12 December 2020

Coadministration of itraconazole with hypolipidemic agents may induce rhabdomyolysis in healthy individuals

1 reference

12 December 2020

Warfarin-fluconazole. I. Inhibition of the human cytochrome P450-dependent metabolism of warfarin by fluconazole: in vitro studies

1 reference

12 December 2020

Characterization of the in vitro biotransformation of the HIV-1 reverse transcriptase inhibitor nevirapine by human hepatic cytochromes P-450

1 reference

12 December 2020

Insulin resistance in HIV protease inhibitor-associated diabetes

1 reference

12 December 2020

Angiotensin II receptor antagonists: an emerging new class of cardiovascular therapeutics

1 reference

12 December 2020

Consensus for the use of fibrates in the treatment of dyslipoproteinemia and coronary heart disease. Fibrate Consensus Group

1 reference

12 December 2020

Potential interaction involving warfarin and ritonavir

1 reference

12 December 2020

Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients.

1 reference

12 December 2020

Plasma concentration profiles of simvastatin 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase inhibitory activity in kidney transplant recipients with and without ciclosporin

1 reference

12 December 2020

Coronary artery disease occurring with protease inhibitor therapy

1 reference

12 December 2020

Safety and efficacy of eprosartan, a new angiotensin II receptor blocker

1 reference

12 December 2020

Ischemic cardiovascular disease in persons with human immunodeficiency virus infection.

1 reference

12 December 2020

Effect of fluconazole on the pharmacokinetics of eprosartan and losartan in healthy male volunteers

1 reference

12 December 2020

Visceral abdominal-fat accumulation associated with use of indinavir

1 reference

12 December 2020

Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy

1 reference

12 December 2020

Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole.

1 reference

12 December 2020

The effect of ketoconazole on the pharmacokinetics, pharmacodynamics and safety of nisoldipine

1 reference

12 December 2020

Effect of ritonavir on the pharmacokinetics of ethinyl oestradiol in healthy female volunteers

1 reference

12 December 2020

Use of quinidine inhibition to define the role of the sparteine/debrisoquine cytochrome P450 in metoprolol oxidation by human liver microsomes

1 reference

12 December 2020

Comparison of pharmacokinetic properties of beta-adrenoceptor blocking drugs

1 reference

12 December 2020

A potent PPARalpha agonist stimulates mitochondrial fatty acid beta-oxidation in liver and skeletal muscle

1 reference

12 December 2020

Oxidation of dihydropyridine calcium channel blockers and analogues by human liver cytochrome P-450 IIIA4.

1 reference

12 December 2020

Interaction of delavirdine with human liver microsomal cytochrome P450: inhibition of CYP2C9, CYP2C19, and CYP2D6.

1 reference

12 December 2020

Micronized fenofibrate: a new fibric acid hypolipidemic agent

1 reference

12 December 2020

In vitro approaches to predicting drug interactions in vivo.

1 reference

12 December 2020

Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV Cohort Study

1 reference

12 December 2020

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

12 December 2020

In vitro metabolism of simvastatin in humans [SBT]identification of metabolizing enzymes and effect of the drug on hepatic P450s

1 reference

12 December 2020

Lactonization is the critical first step in the disposition of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor atorvastatin.

1 reference

12 December 2020

Effect of itraconazole on the pharmacokinetics of atorvastatin

1 reference

12 December 2020

New approaches to the uses of beta blocking drugs in hypertension

1 reference

12 December 2020

Severe premature coronary artery disease with protease inhibitors

1 reference

12 December 2020

Rhabdomyolysis due to interaction of simvastatin with mibefradil

1 reference

12 December 2020

Myositis and rhabdomyolysis associated with concurrent use of simvastatin and nefazodone

1 reference

12 December 2020

Multiple organ toxicity from addition of erythromycin to long-term lovastatin therapy

1 reference

12 December 2020

Pharmacokinetic interactions between nelfinavir and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors atorvastatin and simvastatin

1 reference

12 December 2020

The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions

1 reference

12 December 2020

Propranolol's metabolism is determined by both mephenytoin and debrisoquin hydroxylase activities

1 reference

12 December 2020

"Buffalo hump" in men with HIV-1 infection.

1 reference

12 December 2020

Effect of fluconazole on plasma fluvastatin and pravastatin concentrations

1 reference

12 December 2020

In vitro comparative inhibition profiles of major human drug metabolising cytochrome P450 isozymes (CYP2C9, CYP2D6 and CYP3A4) by HMG-CoA reductase inhibitors

1 reference

12 December 2020

Indinavir-associated lipodystrophy.

1 reference

12 December 2020

Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study

1 reference

12 December 2020

Troglitazone increases cytochrome P-450 3A protein and activity in primary cultures of human hepatocytes

1 reference

12 December 2020

Cotrimoxazole as an inhibitor of oxidative drug metabolism: effects of trimethoprim and sulphamethoxazole separately and combined on tolbutamide disposition

1 reference

12 December 2020

Indinavir and systemic hypertension

1 reference

12 December 2020

Inhibition of human cytochrome P450 isoforms by nonnucleoside reverse transcriptase inhibitors

1 reference

12 December 2020

Role of CYP2C9 polymorphism in losartan oxidation

1 reference

12 December 2020

Treatment of osteoporosis with bisphosphonates

1 reference

12 December 2020

Fluconazole but not itraconazole decreases the metabolism of losartan to E-3174

1 reference

12 December 2020

Myocardial infarction in HIV-infected men receiving protease inhibitors

1 reference

12 December 2020

Clinical pharmacokinetics of metformin

1 reference

12 December 2020

Cytochrome P450 isozymes involved in propranolol metabolism in human liver microsomes. The role of CYP2D6 as ring-hydroxylase and CYP1A2 as N-desisopropylase

1 reference

12 December 2020

HIV-protease inhibitors

1 reference

12 December 2020

Calcium channel modulators of the dihydropyridine family are human pregnane X receptor activators and inducers of CYP3A, CYP2B, and CYP2C in human hepatocytes

1 reference

12 December 2020

Small intestinal metabolism of the 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor lovastatin and comparison with pravastatin

1 reference

12 December 2020

Pharmacologic, pharmacokinetic, and therapeutic differences among angiotensin II receptor antagonists

1 reference

12 December 2020

Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy

1 reference

12 December 2020

Repaglinide: a review of its therapeutic use in type 2 diabetes mellitus

1 reference

12 December 2020

The influence of verapamil on serum digoxin concentration

1 reference

12 December 2020

Risedronate: a review of its pharmacological properties and clinical use in resorptive bone disease

1 reference

12 December 2020

Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG Study A5047.

1 reference

12 December 2020

Assessment of drug-drug interactions: concepts and approaches

1 reference

12 December 2020

Biotransformation of pravastatin sodium in humans

1 reference

12 December 2020

Itraconazole drastically increases plasma concentrations of lovastatin and lovastatin acid

1 reference

12 December 2020

Clinical pharmacokinetics of troglitazone

1 reference

12 December 2020

Identification of P450 enzymes involved in metabolism of verapamil in humans

1 reference

12 December 2020

Losartan potassium: a review of its pharmacology, clinical efficacy and tolerability in the management of hypertension

1 reference

12 December 2020

Diltiazem inhibition of cytochrome P-450 3A activity is due to metabolite intermediate complex formation

1 reference

12 December 2020

Cytochrome P4502C9: an enzyme of major importance in human drug metabolism

1 reference

12 December 2020

1 reference

12 December 2020

Lack of effect of grapefruit juice on the pharmacokinetics and pharmacodynamics of amlodipine

1 reference

12 December 2020

Rhabdomyolysis from the coadministration of lovastatin and the antifungal agent itraconazole

1 reference

12 December 2020

Osteonecrosis in HIV: a case-control study

1 reference

12 December 2020

PPAR gamma and the treatment of insulin resistance

1 reference

12 December 2020

Raloxifene hydrochloride

1 reference

12 December 2020

A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. European-Australian Collaborative Ritonavir Study Group

1 reference

12 December 2020

Effect of saquinavir on the pharmacokinetics and pharmacodynamics of oral and intravenous midazolam.

1 reference

12 December 2020

Ritonavir. Clinical pharmacokinetics and interactions with other anti-HIV agents

1 reference

12 December 2020

Itraconazole greatly increases plasma concentrations and effects of felodipine.

1 reference

12 December 2020

Tolbutamide and mephenytoin hydroxylation by human cytochrome P450s in the CYP2C subfamily

1 reference

12 December 2020

Symptomatic hypoglycemia secondary to a glipizide-trimethoprim/sulfamethoxazole drug interaction

1 reference

12 December 2020

Different effects of itraconazole on the pharmacokinetics of fluvastatin and lovastatin

1 reference

12 December 2020

Metabolism of amprenavir in liver microsomes: role of CYP3A4 inhibition for drug interactions.

1 reference

12 December 2020

Repaglinide, a novel, short-acting hypoglycemic agent for type 2 diabetes mellitus

1 reference

12 December 2020

Effect of troglitazone on cytochrome P450 enzymes in primary cultures of human and rat hepatocytes

1 reference

12 December 2020

Hyperlipidemia under treatment with proteinase inhibitors

1 reference

12 December 2020

Pharmacogenetic explanation for excessive beta-blockade following timolol eye drops. Potential for oral-ophthalmic drug interaction

1 reference

12 December 2020

Relationship between time after intake of grapefruit juice and the effect on pharmacokinetics and pharmacodynamics of nisoldipine in healthy subjects

1 reference

12 December 2020

In vivo inhibition profile of cytochrome P450TB (CYP2C9) by (±)-fluvastatin*

1 reference

12 December 2020

Peptide mimetic HIV protease inhibitors are ligands for the orphan receptor SXR.

1 reference

12 December 2020